Zydus Cadila has received final approval from US Food and Drug Administration (USFDA) to market Acyclovir Sodium Injection, 500 mg (base)/10 mL (50 mg (base)/ml) and 1,000 mg (base)/20mL (50 mg (base)/mL) single-dose vials (US RLD-Zovirax for injection). It will be manufactured at the group's formulations manufacturing facility at Moraiya in Ahmedabad.
Acyclovir is an antiviral drug. It slows the growth and spread of the herpes virus in the body. Acyclovir injection is used to treat severe infections caused by herpes viruses. The group now has 216 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1535.60 |
Dr. Reddys Lab | 5834.25 |
Cipla | 1424.50 |
Zydus Lifesciences | 1008.50 |
Lupin | 1660.35 |
View more.. |